$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
출원번호 US-0769574 (2004-01-29)
등록번호 US7976870 (2011-06-28)
발명자 / 주소
  • Berner, Bret
  • Louie-Helm, Jenny
  • Shell, John W.
출원인 / 주소
  • Depomed, Inc.
대리인 / 주소
    Paul B., Simboli
인용정보 피인용 횟수 : 33  인용 특허 : 62

초록

Controlled release oral dosage forms are provided for the continuous, sustained administration of a pharmacologically active agent to the upper gastrointestinal tract of a patient in whom the fed mode as been induced. The majority of the agent is delivered, on an extended release basis, to the stoma

대표청구항

We claim: 1. A method for delivering a pharmacologically active agent, the method comprising:orally administering to a patient in a fed mode a matrix/active agent tablet dosage form comprised of a polymer matrix and the pharmacologically active agent dispersed in said polymer matrix, said polymer ma

이 특허에 인용된 특허 (62)

  1. Shell John W. (Hillsborough CA), Alkyl-substituted cellulose-based sustained-release oral drug dosage forms.
  2. Bar-Shalom Daniel (Kokkedal DKX) Kindt-Larsen (Vedbaek DKX), Controlled release article with pulsatile release.
  3. Edgren David E. (El Granada CA) Magruder Judy A. (Palo Alto CA) Bhatti Gurdish K. (Fremont CA), Controlled release dosage form comprising different cellulose ethers.
  4. Fassihi Reza ; Yang Libo, Controlled release drug delivery system.
  5. Chen Chih-Ming ; Lee Der-Yang ; Xie Jianbo, Controlled release formulation for water insoluble drugs in which a passageway is formed in situ.
  6. Krishnamurthy Thinnayam N.,CAX, Controlled release matrix for pharmaceuticals.
  7. Dandiker Yogendra (Ware GB3) Huckle Paul D. (Ware GB3), Controlled release pharmaceutical compositions.
  8. Conte Ubaldo (Busto-Arsizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Controlled release pharmaceutical tablet having lenticular form.
  9. Maggi Lauretta,ITX ; Conte Ubaldo,ITX ; Grenier Pascal,FRX ; Vergnault Guy,FRX ; Zimmer Robert,FRX, Controlled release pharmaceutical tablets containing an active principle of low water solubility.
  10. Kim Cherng-ju, Controlled release tablet.
  11. Chen Chih-Ming (Cooper City FL), Controlled release tablet formulation.
  12. Chen Chih-Ming (Cooper City FL) Chiao Charles S. L. (Cooper City FL) Suarz Jos (Miami FL), Controlled release tablet formulation.
  13. Bauer Kurt Heinz (Freiburg DEX) Betzing Juergen (Aachen DEX), Crosslinked polysaccharides, process for their preparation and their use.
  14. Edgren David E. (El Granada CA) Magruder Judy A. (Palo Alto CA) Bhatti Gurdish K. (Fremont CA), Dosage form comprising parallel lamine.
  15. Urquhart John (Palo Alto CA) Theeuwes Felix (Los Altos CA), Drug delivery system comprising a reservoir containing a plurality of tiny pills.
  16. Urquhart John (Palo Alto CA) Theeuwes Felix (Los Altos CA), Drug delivery system with means for obtaining desirable in vivo release rate pattern.
  17. Penners Gunther (Leverkusen DEX) Lustig Klemens (Wuppertal DEX) Petersen-von Gehr Jorg (Bochum DEX), Expandable pharmaceutical forms.
  18. Stevens Howard Norman Ernest,GBX ; Rashid Abdul,GBX ; Bakhshaee Massoud,GBX ; Binns Julie Stephanie,GBX ; Miller Christopher Jon,GBX, Expulsion of material from a delivery device.
  19. John W. Shell ; Jenny Louie-Helm ; Micheline Markey, Extending the duration of drug release within the stomach during the fed mode.
  20. Curatolo William J. (Niantic CT) Lo Jeelin (Old Lyme CT), Gastric retention system for controlled drug release.
  21. Shell John W. ; Louie-Helm Jenny, Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter.
  22. Lerner E. Itzhak,ILX ; Flashner Moshe,ILX ; Penhasi Adel,ILX, Gastrointestinal drug delivery system.
  23. Illum Lisbeth,GBX ; Ping He, Gastroretentive controlled release microspheres for improved drug delivery.
  24. Chen Chih-Ming ; Chou Joseph ; Wong David, HMG co-reductase inhibitor.
  25. Verne E. Cowles, Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists.
  26. Nishioka Takaaki,JPX ; Kuratani Kenji,JPX ; Kanasaki Haruo,JPX ; Luchtenberg Helmut,DEX ; Tenter Ulrich,DEX ; Ohm Andreas,DEX, Long-lasting release nifedipine preparation.
  27. Geary Richard S. (San Antonio TX) Schlameus Herman W. (San Antonio TX), Microparticulate pharmaceutical delivery system.
  28. Colombo Paolo (Milan ITX) Cardona Antonio C. (Milan ITX) Pifferi Giorgio (Milan ITX), Multilayer matrix systems for the controlled release of active principles.
  29. Conte Ubaldo (Pavia ITX) Maggi Lauretta (Pavia ITX) Giunchedi Paolo (Pavia ITX), Multilayered controlled-release oral solid pharmaceutical forms.
  30. Chen Chih-Ming (Cooper City FL), Multiparticulate pulsatile drug delivery system.
  31. Chen Chih-Ming ; Chou Joseph C. H., Once daily pharmaceutical tablet having a unitary core.
  32. Talwar Naresh,INX ; Sen Himadri,INX ; Staniforth John N.,GBX, Orally administered controlled drug delivery system providing temporal and spatial control.
  33. Herbig Scott M. (Becd OR) Smith Kelly L. (Becd OR), PH-triggered osmotic bursting delivery devices.
  34. Infeld Martin H. (Upper Montclair NJ) Malick A. Waseem (Edison NJ) Shah Navnit H. (Clifton NJ) Phuapradit Wantanee (Kearny NJ), Pharmaceutical compositions with constant erosion volume for zero order controlled release.
  35. Conte Ubaldo,ITX ; La Manna Aldo,ITX ; Maggi Lauretta,ITX, Pharmaceutical tablet capable of liberating one or more drugs at different release rates.
  36. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times.
  37. Conte Ubaldo,ITX ; Maggi Lauretta,ITX, Pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids.
  38. Conte Ubaldo,ITX ; Maggi Lauretta,ITX ; Grenier Pascal,FRX ; Vergnault Guy,FRX ; Zimmer Robert,FRX, Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption.
  39. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Pharmaceutical tablets releasing the active substance after a definite period of time.
  40. Conte Ubaldo (Busto Arisizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Process for preparing pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent.
  41. Tams va (Gdllo HUX) Fekete Pl (Budapest HUX) Kovcs Tibor (Szentendre HUX) Bezzegh Dnes (Budapest HUX) Br ne Baumgartner Ilona (Budapest HUX) Tth Zoltn (Budapest HUX) Zukovics ne Smeg Katalin (Budapes, Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content.
  42. Wong Patrick S. L. ; Dong Liang-Chang ; Edgren David E. ; Theeuwes Felix ; Gardner Phyllis I. ; Jao Francisco ; Wan Jason J., Prolonged release active agent dosage form adapted for gastric retention.
  43. Bai Jane Pei-Fan, Pulsatile drug delivery system.
  44. Chen Chih-Ming (Cooper City FL), Pulsatile particles drug delivery system.
  45. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  46. Powell David R. (Baudette MN) Patel Vithal K. (Baudette MN), Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range.
  47. Sako, Kazuhiro; Sawada, Toyohiro; Yoshihara, Keiichi; Yoshioka, Tatsunobu; Watanabe, Shunsuke, Stable pharmaceutical composition for oral use.
  48. Baichwal Anand R., Sustained release matrix for high-dose insoluble drugs.
  49. Pawan Seth, Sustained release pharmaceutical composition free of food effect.
  50. Nayak Ammunje S. (Great Meadows NJ), Sustained release pharmaceutical preparations containing an analgesic and a decongestant.
  51. Uemura Toshinobu (Kishiwada JPX) Shinooka Kiyohide (Nishinomiya JPX) Kajiho Tokuaki (Kobe JPX), Sustained release tablet.
  52. Oren Peter L. (Noblesville IN) Seidler Werner M. K. (Indianapolis IN), Sustained release tablets.
  53. Franz Michel R. (Brussels BEX) Oth Marianne P. (Brussels BEX), Sustained release, bilayer buoyant dosage form.
  54. Shell John W. (Hillsborough CA), Sustained-release oral drug dosage form.
  55. Colombo Paolo (Pavia ITX) La Manna Aldo (Pavia ITX) Conte Ubaldo (Busto Arsizio ITX), System for the controlled-rate release of active substances.
  56. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Colombo Paolo (Pavia ITX), Tablet for pharmaceutical use able to release active substances at successive times.
  57. Qiu Yihong ; Trivedi Jay S. ; Graham Sharon L. ; Flood Kolette M. ; Krill Steven L., Tablet for the controlled release of active agents.
  58. Bret Berner ; Jenny Louie-Helm, Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms.
  59. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Colombo Paolo (Pavia ITX), Tablets with controlled-rate release of active substances.
  60. Davis John D. (Grossepointe Farms MI) Touitou Elka (Jerusalem ILX) Rubinstein Ardon (Jerusalem ILX), Targeted enternal delivery system.
  61. Busetti Cesare,ITX ; Crimella Tiziano,ITX, Time-specific controlled release dosage formulations and method of preparing same.
  62. Gergely Gerhard (Vienna ATX) Gergely Irmgard (Vienna ATX) Gergely Thomas (Vienna ATX), Uncoated pharmaceutical reaction tablet.

이 특허를 인용한 특허 (33)

  1. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  2. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  3. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  4. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai; Chow, San-Laung; Lin, Edward; Wong, David, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  5. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  6. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  7. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Extended-release minocycline dosage forms.
  8. Sommer, Andreas; Zhang, Chengzhi; Carter, John; Arthur, John; Bradbury, Margaret; Gant, Thomas; Shahbaz, Manouchehr, Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2.
  9. Sommer, Andreas; Zhang, Chengzhi; Carter, John; Arthur, John; Bradbury, Margaret; Gant, Thomas; Shahbaz, Manouchehr, Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2.
  10. Sommer, Andreas; Zhang, Chengzhi; Carter, John; Arthur, John; Bradbury, Margaret; Gant, Thomas; Shahbaz, Manouchehr, Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2.
  11. Sommer, Andreas; Zhang, Chengzhi; Carter, John; Arthur, John; Bradbury, Margaret; Gant, Thomas; Shahbaz, Manouchehr, Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2.
  12. Sommer, Andreas; Zhang, Chengzhi; Carter, John; Arthur, John; Bradbury, Margaret; Gant, Thomas; Shahbaz, Manouchehr, Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2.
  13. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  14. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  15. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  16. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for doxycycline.
  17. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for minocycline.
  18. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  19. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  20. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  21. Saint, Sean, Method and device utilizing insulin delivery protocols.
  22. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Method for the treatment of acne and certain dosage forms thereof.
  23. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  24. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  25. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  26. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  27. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  28. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  29. Rosinko, Mike, Simplified insulin pump for type II diabetics.
  30. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  31. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  32. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  33. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트